Aurora Cannabis Inc. (NASDAQ:ACB) saw a downside of -1.71% to close Tuesday at $0.49 after subtracting -$0.01 on the day. The 5-day average trading volume is 4,045,720 shares of the company’s common stock. It has gained $0.5200 in the past week and touched a new high 1 time within the past 5 days. An average of 4,733,295 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 4,227,194.
ACB’s 1-month performance is -1.83% or -$0.0158 on its low of $0.4820 reached on 07/26/23. The company’s shares have touched a 52-week low of $0.48 and high of $1.73, with the stock’s rally to the 52-week high happening on 02/02/23. YTD, ACB has lost -46.94% or -$0.4331 and has reached a new high 7 times. However, the current price is down -71.63% from the 52-week high price.
Valuation Metrics
ACB stock has a beta of 2.55. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.01 while the price-to-book (PB) in the most recent quarter is 0.36.
Aurora Cannabis Inc.’s quick ratio for the period ended March 30 was 1.60, with the current ratio over the same period at 2.30. As well, the company’s long term debt to equity for the quarter ending March 30 was 0.16, while the total debt to equity was 0.33.. In terms of profitability, the gross margin trailing 12 months is -14.90%. The trailing 12-month EBITDA margin is -90.34% while for the period ending March 30, Aurora Cannabis Inc.’s operating margin was -97.30%. The firm’s gross profit as reported stood at $16.77 million against revenue of $174.88 million.
Earnings Surprise
For the quarterly period ending March 30 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 100.0% to -$1.32 billion, while revenue of $0.0 was 100.0% off the previous quarter. Analysts expected ACB to announce -$0.05 per share in earnings in its latest quarter, but it posted -$0.18, representing a -260.00% surprise. EBITDA for the quarter stood at more than -$11.99 million. ACB stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 241.18 million, with total debt at $156.38 million.
Let’s look briefly at Aurora Cannabis Inc. (ACB) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 22 August was 33.59% to suggest the stock is trending Neutral, with historical volatility in this time period at 33.06%.
The stock’s 5-day moving average is $0.5025, reflecting a -6.41% or -$0.0335 change from its current price. ACB is currently trading -0.67% above its 20-day SMA, -28.79% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -7.64% and SMA200 by-60.84%.
Stochastic %K and %D was 8.47% and 15.42% and the average true range (ATR) pointed at 0.0248. The RSI (14) points at 38.71%, while the 14-day stochastic is at 5.31% with the period’s ATR at 0.0269. The stock’s 9-day MACD Oscillator is pointing at -0.0158 and -0.0270 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Aurora Cannabis Inc. (NASDAQ: ACB), Canaccord Genuity upgraded it to a Hold rating. They previously had a Sell rating on the stock. Analysts offering their rating for ACB stock have a consensus rating for the stock as Hold. Currently, 0 brokerage advisors rate ACB as a “sell,”, while 8 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 0 have offered a “buy” rating.
What is ACB’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $0.51 and a high of $1.12, with their median price target at $0.67. Looking at these predictions, the average price target given by analysts is for Aurora Cannabis Inc. (ACB) stock is $0.74.
